Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists
Michail V. Sitkovsky, Stephen Hatfield, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Akio Ohta
Research output: Contribution to journal › Review article › peer-review
Fingerprint
Dive into the research topics of 'Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists'. Together they form a unique fingerprint.